Status:
COMPLETED
Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Collaborating Sponsors:
Rigshospitalet, Denmark
University Hospital, Gentofte, Copenhagen
Conditions:
Retinal Degeneration
Diabetic Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.
Detailed Description
The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid a...
Eligibility Criteria
Inclusion
- Ocular ischemic syndrome
Exclusion
- Any other active ocular disease
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00403195
Start Date
November 1 2006
End Date
January 1 2009
Last Update
September 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Glostrup Hospital, University of Copenhagen
Glostrup Municipality, Denmark, 2600